$TELA Cashflow Statement | Understand Stock

$TELA

$0.96 -$0.02 (2.19%) Close

$TELA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Noncash interest expense
Noncash loss on extinguishment of debt
Amortization of intangible assets
Net changes in operating lease ROU assets and liabilities
Inventory excess and obsolescence charge
Stock-based compensation expense
Deferred income tax expense (benefit)
Income tax expense (benefit)
Gain on disposal of fixed assets
Gain on sale of product line
Change in operating assets and liabilities:
Accounts receivable, net
Inventory
Prepaid expenses and other current and long-term assets
Accounts payable
Accrued expenses and other current and long-term liabilities
Foreign currency transaction loss
Net cash used in operating activities
Cash flows from investing activities:
Payment for intangible asset
Purchase of property and equipment
Proceeds from the sale of product line
Proceeds from the sale of property and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from sale of common stock and pre-funded warrants, net
Proceeds from issuance of long-term debt
Proceeds from issuance of long-term debt and warrants
Repayment of long-term debt
Payment of debt financing costs
Proceeds from exercise of stock options
Payment of withholding taxes related to stock-based compensation to employees
Proceeds from issuance of common stock under the employee stock purchase plan
Net cash provided by financing activities

Effect of exchange rate on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash, beginning of year
Cash and cash equivalents and restricted cash, end of year
Supplemental disclosure of cash flow information:
Cash paid during the period for interest
Supplemental disclosures of noncash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities
Issuance of common stock for early exercised stock options
Reclassification of liability-classified stock-based compensation awards to equity-classified
Operating lease ROU asset exchanged for operating lease liabilities
Tenant improvement and deferred rent reclassified to operating lease liabilities
Operating lease liabilities assumed for operating lease ROU assets
Offering costs in accrued expenses and other current liabilities
Issuance of common stock warrants in connection with credit facility

Comments